Why Rezolute, Inc.’s (RZLT) Stock Is Up 6.33%

By Jenna Brashear
May 21, 2025
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Rezolute, Inc. before investing.

In this article, we go over a few key elements for understanding Rezolute, Inc.’s stock price such as:

  • Rezolute, Inc.’s current stock price and volume
  • Why Rezolute, Inc.’s stock price changed recently
  • Upgrades and downgrades for RZLT from analysts
  • RZLT’s stock price momentum as measured by its relative strength

About Rezolute, Inc. (RZLT)

Before we jump into Rezolute, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. The company’s lead product candidate is ersodetug, a human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 2 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.

Want to learn more about Rezolute, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Rezolute, Inc..

Learn More About A+ Investor

Rezolute, Inc.’s Stock Price as of Market Close

As of May 21, 2025, 12:47 PM, CST, Rezolute, Inc.’s stock price was $4.290.

Rezolute, Inc. is up 8.61% from its previous closing price of $3.950.

During the last market session, Rezolute, Inc.’s stock traded between $3.840 and $4.330. Currently, there are approximately 70.03 million shares outstanding for Rezolute, Inc..

Rezolute, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Rezolute, Inc. Stock Price History

Rezolute, Inc.’s (RZLT) price is currently up 14.09% so far this month.

During the month of May, Rezolute, Inc.’s stock price has reached a high of $4.330 and a low of $3.320.

Over the last year, Rezolute, Inc. has hit prices as high as $6.186 and as low as $2.215. Year to date, Rezolute, Inc.’s stock is down 12.45%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Rezolute, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 20, 2025, there was 1 analyst who downgraded Rezolute, Inc.’s stock and 4 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Rezolute, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Rezolute, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Rezolute, Inc. (RZLT) by visiting AAII Stock Evaluator.

Relative Price Strength of Rezolute, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 20, 2025, Rezolute, Inc. has a weighted four-quarter relative price strength of 6.24%, which translates to a Momentum Score of 79 and is considered to be Strong.

Want to learn more about how Rezolute, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Rezolute, Inc. Stock Price: Bottom Line

As of May 21, 2025, Rezolute, Inc.’s stock price is $4.290, which is up 8.61% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Rezolute, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
O'Neil CAN SLIM Screen: 38.3% Compared to S&P 500
at only 23.3%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.